Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Elan to return $1 billion to shareholders from multiple sclerosis drug sale
Elan to return $1 billion to shareholders from multiple sclerosis drug sale
Elan to return $1 billion to shareholders from multiple sclerosis drug sale
Submitted by
admin
on February 22, 2013 - 10:44am
Source:
Reuters
News Tags:
Elan
Tysabri
share repurchase
Headline:
Elan to return $1 billion to shareholders from multiple sclerosis drug sale
Do Not Allow Advertisers to Use My Personal information
